H&T Presspart, the world’s leading manufacturer of components for respiratory drug delivery systems and devices, are pleased to announce they will be presenting at this year’s Drug Delivery Partnership conference, held in Florida, USA from 22-24 January

Mr Dana Shears, H&T Presspart Director for Future Market Developments, will be delivering a speech on ‘Smart Inhalers – Improving Patient Adherence and Reducing Healthcare Costs’ on Monday 22nd January at 3.15pm in the Track 2: Drug Delivery Technologies to Watch section of the conference.

Mr Shears will discuss how poor patient adherence is contributing to rising healthcare costs, and how smart inhalers enable more effective monitoring of patient adherence and compliance. Clinical studies using smart devices have demonstrated improvements and translate directly to a reduction in healthcare cost. Smart Inhalers face numerous challenges, from a wide range of stakeholder, for successful adoption on a global scale.

H&T Presspart will also be exhibiting their full range of respiratory drug delivery components and devices during the conference on table 200 of the exhibiton hall. Visitors will be able to try out  the eMDI connected inhaler for themselves, as well as viewing our range of metered-dose inhaler components including MDI actuators and MDI canisters.

H&T Pressparts range of MDI components

For 22 years, DDP has been the world’s largest drug delivery meeting place to accelerate drugs to market and lengthen lifecycles for long term profitability by finding new partners, new drug delivery technologies, and new formulation development strategies.

For more information on the show please visit the Drug Delivery Partnership website.